[EN] COMPOUNDS THAT INHIBIT MCL-1 PROTEIN<br/>[FR] COMPOSÉS INHIBANT LA PROTÉINE MCL-1
申请人:AMGEN INC
公开号:WO2017147410A1
公开(公告)日:2017-08-31
Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I, and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.
Investigation of Bis(tributyltin)-Initiated Free Radical Cyclization Reactions of 4-Pentenyl Iodoacetates
作者:Junhua Wang、Chaozhong Li
DOI:10.1021/jo0109568
日期:2002.2.1
free radical cyclization to generate gamma-iodoheptanolactones which easily underwent intramolecular nucleophilicsubstitution to form bicyclic acylium species (7) as the key intermediate. Subsequent attack by iodide ion furnished gamma-lactones while attack by hydroxide ion gave the tetrahydrofuran derivatives.
Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
申请人:Pain Gilles
公开号:US20100280018A1
公开(公告)日:2010-11-04
A compound of formula (I), or an enantiomer or diastereoisomer thereof, or a salt, hydrate or solvate thereof:
for the treatment or prophylaxis of arthritis in mammals.